cbdMD, Inc. Cash Flow Statement
YCBD|9 years of annual SEC 10-K data (FY2017-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$352,792
FY2025
Free Cash Flow
-$542,807
FY2025
Capital Expenditures
$190,015
Cash used for long-term assets
Dividends Paid
N/A
FY2025
cbdMD, Inc. used $352,792 in operating cash flow and negative free cash flow of $542,807 in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.7M | -$22.9M | -$70.1M | -$23.4M | $12.6M | -$51.4M | $62.8K | -$1.4M | -$3.9M |
| Depreciation & Amortization | $452.3K | $404.3K | $949.0K | $1.0M | $720.8K | $289.6K | $222.5K | $71.3K | $44.9K |
| Operating Cash Flow | -$352.8K | -$4.3M | -$15.0M | -$14.1M | -$10.7M | -$15.4M | -$5.6M | -$2.3M | -$2.9M |
| Capital Expenditures | $190.0K | $297.5K | $688.7K | $342.0K | $1.3M | $1.2M | $23.6K | $8.0K | $127.3K |
| Free Cash Flow | -$542.8K | -$4.6M | -$15.7M | -$14.4M | -$12.0M | -$16.6M | -$5.6M | -$2.3M | -$3.0M |
| Dividends Paid | - | - | - | - | $366.9K | $0 | - | - | - |
| FCF Margin | -2.8% | -19.0% | -44.2% | -32.5% | -28.6% | -70.1% | -1219.1% | -52.2% | -148.9% |